Multicenter Evaluation of a New Screening Test That Detects Clostridium difficile in Fecal Specimens
AUTOR(ES)
Zheng, L.
FONTE
American Society for Microbiology
RESUMO
Clostridium difficile causes approximately 25% of nosocomial antibiotic-associated diarrheas and most cases of pseudomembranous colitis. We evaluated C. DIFF CHEK, a new screening test that detects glutamate dehydrogenase of C. difficile. Our results showed that this test was comparable to PCR in sensitivity and specificity and outperformed bacterial culture.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=497597Documentos Relacionados
- Multicenter Evaluation of the Clostridium difficile TOX A/B TEST
- Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.
- Fluorescent-antibody test for detection of Clostridium difficile in stool specimens.
- Proline-aminopeptidase test for rapid screening of Clostridium difficile.
- New rapid identification test for Clostridium difficile.
